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Research
ancer is now the second leading
cause of death, after heart disease, in
Indigenous Australians.1 Although
the age-standardised incidence of all cancers
in Indigenous Australians is similar to that
for the rest of the Australian population,
death rates are up to 45% higher.2 Reasons
for the higher mortality are multifaceted;
they may include diagnosis at a later stage of
cancer, as well as elevated incidence of can-
cer types with higher case-fatality rates (ie,
lung, liver and gallbladder, pancreas, and
stomach cancers).2,3 Cancer registries in the
Northern Territory, Western Australia and
South Australia have published population-
based cancer incidence and mortality rates
for Indigenous people,4 but to date Queens-
land data are available only for selected rural
and remote Indigenous communities.5 Our
aim was to assess incidence and mortality
rates for cancers diagnosed among Indigen-
ous people in all of Queensland.
METHODS
Incidence and mortality data for the
Indigenous and total Queensland popula-
tions for 1997–2006 were obtained from the
Queensland Cancer Registry. Averaged esti-
mates of the Indigenous and total resident
populations of Queensland were obtained
from censuses conducted in 1996, 2001 and
2006.6 Indirectly age-standardised inci-
dence and mortality ratios for Indigenous
Australians in Queensland (compared with
the total Queensland population) were cal-
culated using the total Indigenous resident
population in Queensland and cancer inci-
dence and mortality data for the Indigenous
and total Queensland populations. Compar-
isons were made with cancer rates for the
total Queensland population because only
1% of cancers in Queensland are diagnosed
in people known to be Indigenous.
RESULTS
From 1997 to 2006, 1936 cancer diagnoses
were identified among the Indigenous
Queensland population, representing an
annual incidence rate of 172 per 100000
people. Overall, Indigenous people were 21%
less likely to be diagnosed with cancer than the
total Queensland population (standardised
incidence ratio, 0.79; 95% CI, 0.75–0.82).
Standardised incidence ratios by cancer
type and sex are shown in Box 1. Compared
with the total Queensland population,
Indigenous people had markedly lower rates
of cancers of the skin, breast, prostate, colon
and rectum, bladder, and brain and central
nervous system. Indigenous females experi-
enced an 18% lower incidence of breast
cancer, and Indigenous males were 45% less
likely to develop prostate cancer. Rates of
cancer of the trachea, bronchus and lung,
liver and biliary tract, and oesophagus were
higher for Indigenous people compared
with the state population and, among Indig-
enous females, cervical cancer and uterine
cancer were 3.45 and 2.41 times more
common, respectively.
There were 955 cancer-related deaths in
the Indigenous Queensland population dur-
ing the period 1997–2006; 495 males (mor-
tality rate, 89 deaths per 100 000 people per
year) and 460 females (mortality rate, 80
deaths per 100 000 people per year). Over-
all, Indigenous people were 36% more likely
to die from cancer than the total Queensland
population (standardised mortality ratio,
1.36; 95% CI, 1.28–1.45).
Standardised mortality ratios by cancer
type and sex are shown in Box 2. Cancer-
related death among Indigenous males
was 1.28 times more common (95% CI,
1.17–1.40) and among females was 1.47
times more common (95% CI, 1.33–1.61)
when compared with all Queensland
males and females, respectively. There
were no marked differences in breast can-
cer mortality in females and prostate can-
cer in males compared with the total
Queensland population.
Cancer incidence and mortality rates for
Indigenous people in Queensland were
fairly constant over the 10-year study period
(Box 3).
DISCUSSION
The overall incidence of cancer among
Indigenous people in Queensland for the
period 1997–2006 was 21% lower than in
the total Queensland population but, in
contrast, the mortality rate for all cancers
was 36% higher.
The lower overall incidence of cancer in
Indigenous Queenslanders was mostly due
to lower incidence of colorectal, prostate,
breast and skin cancers, similar to findings
reported for other states and territories.8,9
Age-adjusted incidence rates of trachea,
bronchus and lung cancers were nearly dou-
ble those of other Queenslanders. Cervical
cancer was the third most common cancer
in Indigenous females, in contrast to being
the 14th most common cancer for all
females in Queensland.10 Rates of trachea,
bronchus and lung and cervical cancers
were comparable to rates reported for Indig-
enous people in other Australian jurisdic-
tions.8,11,12 In addition, incidence of uterine
cancer was more than twice as high for
Indigenous females.
Lifestyle factors may have contributed to
increased rates of some cancers. Higher rates
of smoking13,14 may have increased the risk
of lung cancer, and higher rates of hepatitis
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B infection and excessive alcohol consump-
tion (among those Indigenous people who
drink)8,15 may have increased the risk of
liver cancer. Also, lower participation in
cervical cancer screening programs16,17 and
increased rates of obesity, the latter a risk
factor for uterine cancer,18,19 may be associ-
ated with higher rates of cervical and uterine
cancer in Indigenous women.
The higher cancer mortality rate in Indi-
genous Queenslanders was mostly because
of higher mortality due to cancers of the
trachea, bronchus and lung, digestive tract,
head and neck, cervix, and uterus. Diagno-
sis at a later stage of cancer, less uptake of
cancer treatment, and a greater number of
comorbidities may have also contributed to
the higher mortality.3,20
Some evidence suggests that Indigenous
patients are occasionally reluctant to identify
as Indigenous and that hospital staff might
not ask, or might make an educated guess,
about Indigenous status.21 As hospital
records are the primary source of Indigen-
ous status data for the Queensland Cancer
Registry, underreporting of Indigenous sta-
tus may have resulted in underestimation of
cancer incidence in our study. However, this
is unlikely to be substantial as our results
concur with a 2005 Queensland Health
study of cancer in discrete Indigenous com-
munities (where Indigenous status is
assured), which found standardised inci-
dence ratios of 0.70 (95% CI, 0.59–0.83) for
males and 0.79 (95% CI, 0.66–0.94) for
females.22 Also, results of a data quality
audit estimated high rates of correct identifi-
cation of Indigenous status (88% of Indi-
genous patients and 98% of non-Indigenous
patients) in Queensland hospitals.23
From 1997 to 2006, cancer incidence and
mortality in Indigenous people in Queens-
land, a predominantly urbanised popula-
tion, were similar to the cancer rates for
Indigenous people mostly living in remote
areas of Australia.5 A number of the cancers
which contributed to the high mortality rate
are preventable through screening, lifestyle
changes, and implementation of specific
public health initiatives — for example,
culturally appropriate strategies aimed at
reducing tobacco use and obesity could
reduce cancer incidence and mortality.
Advanced cancer at diagnosis, low uptake of
cancer treatment, and high rates of comor-
bidities in Indigenous people appear to be
some of the factors leading to the poorer
outcomes,3,8 hence improved access to and
delivery of culturally appropriate health care
services4 could reduce the disparity in can-
cer outcomes in Australia.
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1 Incidence of cancer in Indigenous Australians in Queensland compared with 
the total Queensland population, 1997–2006
ICD-O-3 = International classification of diseases for oncology, 3rd edition.7 SIR = standardised incidence 
ratio. CNS = central nervous system. * SIR not calculated for two Indigenous males. ◆
Male Female
Cancer type (ICD-O-3 codes) n SIR (95% CI) n SIR (95% CI)
All cancers (C0–C96) 905 0.72 (0.68–0.77) 1031 0.85 (0.80–0.91)
Head and neck (C0–C14) 72 1.29 (1.01–1.62) 35 0.99 (0.69–1.37)
Digestive cancer (C15–C25) 249 1.16 (1.02–1.31) 172 0.89 (0.76–1.03)
Oesophageal (C15) 44 3.32 (2.42–4.46) 11 1.22 (0.61–2.19)
Stomach (C16) 37 1.80 (1.27–2.48) 10 0.68 (0.32–1.24)
Colorectal (C18–C20) 83 0.60 (0.48–0.74) 88 0.67 (0.54–0.83)
Liver and biliary tract (C22–C24) 44 2.89 (2.10–3.88) 34 2.48 (1.72–3.47)
Pancreas (C25) 32 1.70 (1.16–2.39) 18 0.98 (0.58–1.54)
Respiratory (C30–C38) 218 1.82 (1.59–2.08) 127 1.49 (1.24–1.77)
Trachea, bronchus, lung (C33, C34) 194 1.85 (1.59–2.12) 119 1.51 (1.25–1.80)
Bone and cartilage (C40, C41) 4 0.75 (0.20–1.91) 5 0.97 (0.31–2.25)
Melanoma (C44) 13 0.06 (0.03–0.11) 15 0.07 (0.04–0.12)
Mesothelial and soft tissue (C45–C49) 12 0.42 (0.22–0.74) 15 0.93 (0.52–1.53)
Breast (C50)* — — 226 0.82 (0.72–0.94)
Female genital organs (C51–C58) — — 245 2.63 (2.31–2.98)
Cervix (C53) — — 94 3.45 (2.78–4.22)
Corpus uteri (C54) — — 81 2.41 (1.92–3.00)
Ovary (C56) — — 47 1.89 (1.39–2.51)
Male genital organs (C60–C63) 115 0.59 (0.49–0.71) — —
Prostate (C61) 94 0.55 (0.45–0.68) — —
Urinary tract (C64–C68) 56 0.72 (0.54–0.93) 35 0.64 (0.45–0.89)
Bladder (C67) 26 0.59 (0.38–0.86) 19 0.73 (0.44–1.14)
Eye, brain and other CNS (C69–C72) 15 0.49 (0.27–0.80) 10 0.35 (0.17–0.65)
Brain and CNS (C70–C72) 14 0.55 (0.30–0.93) 9 0.39 (0.18–0.74)
Thyroid and other endocrine (C73–C75) 10 0.43 (0.21–0.79) 33 0.87 (0.60–1.22)
Thyroid (C73) 8 0.38 (0.17–0.75) 31 0.87 (0.59–1.23)
Unspecified site (C26, C39, C76–C80) 41 1.40 (1.00–1.90) 36 1.29 (0.90–1.78)
Lymphomas and leukaemias (C42, 
C81–C85, C91–C96)
74 0.73 (0.57–0.92) 49 0.55 (0.41–0.73)
All other neoplasms (C88, C90) 24 0.76 (0.48–1.13) 28 1.02 (0.67–1.47)
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